A Multicenter, Randomized, Double-Blind, Fixed-Dose, 6-Week Trial of Efficacy and Safety of Asenapine Compared with Placebo Using Haloperidol Positive Control in Subjects with an Acute Exacerbation of Schizophrenia
Latest Information Update: 19 Aug 2024
At a glance
- Drugs Asenapine (Primary) ; Haloperidol
- Indications Schizophrenia
- Focus Registrational; Therapeutic Use
- Acronyms HERA
- Sponsors Organon
- 16 Sep 2009 Results of the extension study have been presented at ECNP 2009.
- 31 Dec 2007 Updated status and added endpoints ref 9083604
- 17 Dec 2007 Results reported in a Schering-Plough media release.